Assessment and Diagnosis · 8 min read
Atherosclerosis
Definition and Overview
Atherosclerosis is a chronic, progressive inflammatory disease of medium and large arteries characterized by lipid accumulation, fibrous tissue proliferation, and calcification within the vessel wall. It represents the pathological foundation for coronary artery disease, cerebrovascular disease, and peripheral arterial disease, collectively constituting the leading cause of morbidity and mortality in developed nations.
The term derives from Greek: "athero" (gruel or paste) referring to the lipid core and "sclerosis" (hardening) describing the fibrous cap. Atherosclerosis develops over decades, beginning in childhood with fatty streak formation and progressing to clinically significant plaques in adulthood.
Pathophysiology
Endothelial Dysfunction:
The healthy endothelium performs critical functions: maintaining vascular tone through nitric oxide production, preventing thrombosis through anticoagulant surface properties, regulating inflammation by controlling leukocyte adhesion, and controlling vessel wall permeability. Endothelial dysfunction, the earliest detectable abnormality in atherogenesis, results from injury by cardiovascular risk factors including hypertension, diabetes, smoking, dyslipidemia, and oxidative stress.
Dysfunctional endothelium exhibits reduced nitric oxide bioavailability, increased permeability to lipoproteins, enhanced expression of adhesion molecules (VCAM-1, ICAM-1, E-selectin), and prothrombotic surface changes.
Lipid Accumulation:
Low-density lipoprotein (LDL) particles penetrate the dysfunctional endothelium and accumulate in the subendothelial space (intima). Retained LDL undergoes oxidative modification, creating oxidized LDL (oxLDL), which is highly atherogenic and proinflammatory. OxLDL activates endothelial cells, recruits inflammatory cells, and is cytotoxic to arterial wall components.
High-density lipoprotein (HDL) performs reverse cholesterol transport, removing cholesterol from peripheral tissues and arterial walls for hepatic metabolism. HDL also possesses antioxidant and anti-inflammatory properties, explaining the protective association of elevated HDL levels.
Inflammatory Response:
Activated endothelium expresses adhesion molecules that capture circulating monocytes. Monocytes migrate into the intima under chemotactic gradients (MCP-1) and differentiate into macrophages. Macrophages express scavenger receptors (CD36, SR-A) that avidly internalize oxLDL without feedback regulation, leading to massive lipid accumulation and transformation into foam cells.
Foam cell accumulation creates the fatty streak, the earliest visible lesion. T-lymphocytes also infiltrate the developing lesion and produce cytokines (interferon-gamma, TNF-alpha) that amplify inflammation.
Fibrous Plaque Formation:
Smooth muscle cells migrate from the media to the intima and proliferate under growth factor stimulation (PDGF, TGF-beta). These cells synthesize extracellular matrix components (collagen, elastin, proteoglycans) forming the fibrous cap that covers the lipid-rich necrotic core.
The mature atherosclerotic plaque consists of a fibrous cap (smooth muscle cells, collagen, extracellular matrix) overlying a necrotic core (lipids, cholesterol crystals, cellular debris, calcium deposits). Plaque architecture determines clinical behavior more than stenosis severity.
Plaque Vulnerability and Complications:
Stable plaques have thick fibrous caps, small lipid cores, and low inflammatory activity. They cause gradual luminal narrowing leading to chronic ischemic symptoms (stable angina, claudication).
Vulnerable (unstable) plaques have thin fibrous caps (<65 micrometers), large lipid cores occupying more than 40% of plaque volume, abundant inflammatory cells particularly at cap shoulders, increased matrix metalloproteinase activity degrading collagen, and reduced smooth muscle cell content.
Plaque rupture exposes the thrombogenic necrotic core to circulating blood, triggering platelet aggregation and thrombus formation. This mechanism underlies acute coronary syndromes (unstable angina, myocardial infarction) and ischemic stroke. Plaque erosion, occurring without frank rupture, accounts for approximately 30% of acute coronary events.
Other complications include intraplaque hemorrhage from fragile neovessels, calcification creating rigid vessel segments, and aneurysm formation from medial destruction.
Risk Factors
Non-Modifiable Risk Factors:
Age represents the strongest risk factor, with atherosclerosis progression accelerating after age 45 in men and 55 in women. Family history of premature cardiovascular disease (first-degree male relative <55 years or female <65 years) confers increased risk independent of traditional factors. Male sex carries higher risk, though female risk increases post-menopause. Genetic factors influence lipid metabolism, inflammation, and thrombosis.
Modifiable Risk Factors:
Dyslipidemia constitutes a primary driver of atherogenesis. Elevated LDL cholesterol directly correlates with cardiovascular risk, with each 1 mmol/L reduction decreasing events by approximately 22%. Low HDL cholesterol (<40 mg/dL men, <50 mg/dL women) indicates impaired reverse cholesterol transport. Elevated triglycerides (>150 mg/dL) contribute through remnant particle atherogenicity and association with small dense LDL. Elevated lipoprotein(a) is an independent genetic risk factor.
Hypertension accelerates atherosclerosis through mechanical endothelial injury, increased wall stress, enhanced LDL penetration, and vascular remodeling. Risk increases continuously above 115/75 mmHg without threshold.
Diabetes mellitus accelerates atherosclerosis through multiple mechanisms: hyperglycemia causes advanced glycation end-products formation and oxidative stress; insulin resistance promotes dyslipidemia with elevated triglycerides and small dense LDL; hyperinsulinemia stimulates smooth muscle proliferation; diabetic dyslipidemia includes elevated triglycerides, low HDL, and small dense LDL despite often normal total LDL.
Cigarette smoking damages endothelium, increases LDL oxidation, promotes platelet aggregation, reduces HDL, increases fibrinogen, and induces vasoconstriction. Risk correlates with pack-years but decreases substantially within 2-3 years of cessation.
Obesity, particularly central adiposity, promotes insulin resistance, dyslipidemia, hypertension, and systemic inflammation. Metabolic syndrome (central obesity plus two of: elevated triglycerides, low HDL, elevated blood pressure, elevated fasting glucose) significantly increases cardiovascular risk.
Physical inactivity contributes to obesity, insulin resistance, and dyslipidemia. Regular aerobic exercise improves endothelial function, raises HDL, lowers blood pressure, and reduces inflammation.
Diet high in saturated and trans fats raises LDL cholesterol. Excessive sodium intake contributes to hypertension. Low fruit and vegetable consumption reduces antioxidant protection.
Emerging Risk Factors:
Elevated C-reactive protein (CRP), an inflammatory marker, predicts cardiovascular events independent of traditional risk factors. High-sensitivity CRP testing stratifies intermediate-risk patients.
Elevated homocysteine promotes endothelial dysfunction and thrombosis, though treatment with B vitamins has not reduced cardiovascular events despite lowering levels.
Clinical Manifestations by Vascular Territory
Coronary Artery Disease:
Chronic stable angina results from fixed obstructive plaques causing supply-demand mismatch during exertion. Symptoms include substernal chest pressure, tightness, or heaviness precipitated by physical activity or emotional stress and relieved by rest or nitroglycerin within minutes.
Acute coronary syndromes result from plaque rupture with superimposed thrombosis. Unstable angina presents with new-onset, crescendo, or rest angina without biomarker elevation. Non-ST-elevation myocardial infarction (NSTEMI) shows troponin elevation without ST-segment elevation. ST-elevation myocardial infarction (STEMI) demonstrates persistent ST elevation indicating transmural ischemia requiring emergent reperfusion.
Heart failure may result from ischemic cardiomyopathy due to cumulative myocardial damage or chronic hibernating myocardium.
Cerebrovascular Disease:
Carotid atherosclerosis causes ischemic stroke or transient ischemic attack through thromboembolism or, less commonly, hemodynamic compromise. Symptoms depend on affected territory: anterior circulation (carotid) causes contralateral motor/sensory deficits, aphasia (dominant hemisphere), neglect (non-dominant); posterior circulation (vertebrobasilar) causes diplopia, vertigo, ataxia, bilateral motor/sensory deficits.
Intracranial atherosclerosis affects major cerebral arteries and carries high stroke risk.
Peripheral Arterial Disease:
Lower extremity PAD manifests as intermittent claudication (reproducible muscle pain with walking, relieved by rest), critical limb ischemia (rest pain, ulceration, gangrene), or acute limb ischemia (sudden onset pain, pallor, pulselessness, paresthesias, paralysis, poikilothermia).
Upper extremity PAD is less common but may cause arm claudication, digital ischemia, or subclavian steal syndrome.
Mesenteric ischemia presents as chronic intestinal angina (postprandial pain, food fear, weight loss) or acute mesenteric ischemia (severe abdominal pain out of proportion to examination findings).
Renal artery stenosis causes renovascular hypertension (often resistant or accelerated) and ischemic nephropathy.
Diagnostic Evaluation
Risk Assessment:
Global cardiovascular risk calculators (AHA PREVENT equations, Pooled Cohort Equations, Framingham Risk Score, SCORE2) estimate 10-year risk of atherosclerotic cardiovascular disease events to guide primary prevention intensity. Risk factors are entered and calculated risk stratifies patients into categories determining treatment thresholds.
Laboratory Assessment:
Lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides) guides dyslipidemia management. Fasting glucose and hemoglobin A1c screen for diabetes. High-sensitivity CRP may refine risk in intermediate-risk patients. Complete metabolic panel assesses renal function (affects medication choices) and electrolytes.
Non-Invasive Testing:
Ankle-brachial index (ABI) diagnoses peripheral arterial disease. ABI ≤0.90 indicates PAD; 0.91-0.99 is borderline; 1.00-1.40 is normal; >1.40 suggests calcified, noncompressible vessels (common in diabetes). ABI also predicts systemic cardiovascular risk.
Exercise treadmill testing evaluates suspected coronary artery disease in patients able to exercise with interpretable baseline ECGs. ST-segment depression ≥1mm indicates ischemia.
Coronary artery calcium scoring by non-contrast CT quantifies calcified plaque burden. Scores of 0 indicate low risk; 1-99 mild; 100-399 moderate; ≥400 severe. CAC refines risk assessment in intermediate-risk patients.
CT angiography provides noninvasive coronary artery visualization, assessing stenosis severity and plaque characteristics. It has high negative predictive value for excluding significant CAD.
Carotid ultrasound assesses stenosis severity, plaque morphology, and intima-media thickness. Duplex criteria grade stenosis severity.
Invasive Testing:
Coronary angiography remains the gold standard for coronary artery assessment, providing precise stenosis quantification and allowing intervention. Intravascular ultrasound and optical coherence tomography characterize plaque composition and guide intervention.
Peripheral angiography evaluates extremity, renal, and mesenteric arterial disease when intervention is contemplated.
Nursing Assessment Considerations
The cardiac-vascular nurse systematically assesses for atherosclerotic disease manifestations across all vascular territories. Key assessment elements include comprehensive cardiovascular risk factor inventory, symptom evaluation for each vascular bed, peripheral pulse examination documenting presence, quality, and symmetry, auscultation for carotid, abdominal, and femoral bruits, skin assessment for trophic changes suggesting chronic ischemia, and functional capacity evaluation.
Patient education focuses on risk factor modification, symptom recognition, medication adherence, and lifestyle changes. Early identification of disease progression allows timely intervention.
Finished reading?
Lock it in with a quick Assessment and Diagnosis quiz.